Evidence map›Paper›PMID 23759110›Full record

ArticleThe journal of headache and pain2013

Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study.

Giulia Giannini, Stefano Zanigni, Daniela Grimaldi, Roberto Melotti, Giulia Pierangeli, Pietro Cortelli, Sabina Cevoli

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in The journal of headache and pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03461874 (Feasibility and Effectiveness of Acceptance and Commitment Therapy), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03461874 nacompletednot on this mapstarted 2018, after this paper: background citation

Feasibility and Effectiveness of Acceptance and Commitment Therapy (ACT) for High Frequency Episodic Migraine Without Aura

TypeinterventionalSponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaRan2018 to 2022Enrolled64ConditionsMigraine Without AuraArmsEducation of patients, ACT, Pharmacological prophylaxis
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. ACT for migraine: effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: preliminary data of a phase-II, multicentric, randomized, open-label study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. The sense of stopping migraine prophylaxis.The journal of headache and pain · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Fear, Avoidance, and Disability in Headache Disorders.Current pain and headache reports · 2020
    Review
  18. Article
  19. Triggers, Protectors, and Predictors in Episodic Migraine.Current pain and headache reports · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Giulia Giannini
Stefano Zanigni
Daniela Grimaldi
Roberto Melotti
Giulia Pierangeli
Pietro Cortelli
Sabina Cevoli
Institute of Neurological Sciences · ITEurac Research · ITIstituto delle Scienze Neurologiche di Bologna · ITUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCephalalgiaphobia is the fear of having a headache attack during a pain-free period that may induce patients to use analgesic in the absence of pain to prevent headache and to improve their performances. This study aims at assessing if cephalalgiaphobia is related to migraine frequency or medication overuse, and if it is per se a predictor of increase in migraine frequency.

methodsThis is a pilot prospective cohort study on 126 consecutive migraineurs referred to a tertiary Headache Centre. A headache specialist collected data regarding migraine features, frequency and medications at baseline (T0) and 2 years later (T1). Cephalalgiaphobia was investigated at T0 and T1 through a score determined by a 4 items questionnaire.

resultsModerate-high migraine frequency was associated with higher risk of cephalalgiaphobia (p < 0.001). Chronic migraineurs with medication overuse had higher score of cephalalgiaphobia than those without medication overuse (p < 0.001). Patients with increased migraine frequency between T0 and T1 had higher cephalalgiaphobia score (p < 0.001).

conclusionsCephalalgiaphobia may represent a high-frequency migraine feature and may play a role in chronicization. Therefore, it should be better investigated by clinicians and treated or prevented in order to reduce the risk of disability and the increase in migraine frequency.

Indexed as

AdultAnalgesicsChronic DiseaseCohort StudiesDrug Administration ScheduleFemaleHumansMaleMigraine DisordersPhobic DisordersPilot ProjectsProspective StudiesSelf MedicationAnalgesics

Identifiers

PMID23759110
PMCPMC3686604
OpenAlexW2159614968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.